Diversity in cancer research ensures that findings are applicable to all segments of the population. Historically, clinical trials and studies have underrepresented minorities and women, leading to gaps in knowledge about how these groups respond to cancer treatments. Diverse participation can help identify genetic variations that influence cancer susceptibility and treatment outcomes, leading to more personalized and effective therapies.
